Key Laboratory for Advanced Materials & Institute of Fine Chemicals and School of Pharmacy, East China University of Science and Technology, Shanghai, PR China.
Bioorg Med Chem. 2011 Jul 1;19(13):3892-900. doi: 10.1016/j.bmc.2011.05.049. Epub 2011 May 27.
Protein tyrosine phosphatases (PTPs) are well-validated therapeutic targets for many human major diseases. The development of their potent inhibitors has therefore become a main focus of both academia and the pharmaceutical industry. We report herein a facile strategy toward the fabrication of new and competent PTP inhibitor entities by simply 'clicking' alkynyl amino acids onto diverse azido sugar templates. Triazolyl glucosyl, galactosyl, and mannosyl serine and threonine derivatives were efficiently synthesized via click reaction, which were then identified as potent CDC25B and PTP1B inhibitors selective over a panel of homologous PTPs tested. Their inhibitory activity and selectivity were found to largely lie on the structurally and configurationally diversified monosaccharide moieties whereon serinyl and threoninyl residues were introduced. In addition, MTT assay revealed the triazole-connected sugar-amino acid hybrids may also inhibit the growth of several human cancer cell lines including A549, Hela, and especially HCT-116. On the basis of such compelling evidence, we consider that this compound series could furnish promising chemical entities serving as new CDC25B and PTP1B inhibitors with potential cellular activity. Furthermore, the 'click' strategy starting from easily accessible and biocompatible amino acids and sugar templates would allow the modular fabrication of a rich library of new PTP inhibitors efficaciously and productively.
蛋白质酪氨酸磷酸酶(PTPs)是许多人类重大疾病的经过充分验证的治疗靶点。因此,开发其有效的抑制剂已成为学术界和制药行业的主要关注点。我们在此报告了一种通过简单地将炔基氨基酸“点击”到各种叠氮糖模板上来制备新型有效 PTP 抑制剂实体的简便策略。通过点击反应,高效合成了三唑基葡萄糖基、半乳糖基和甘露糖基丝氨酸和苏氨酸衍生物,它们被鉴定为有效抑制 CDC25B 和 PTP1B 的抑制剂,对测试的同源 PTP 具有选择性。发现它们的抑制活性和选择性在很大程度上取决于结构和构象多样化的单糖部分,其上引入了丝氨酸和苏氨酸残基。此外,MTT 测定表明,三唑连接的糖-氨基酸杂合体也可能抑制包括 A549、Hela 在内的几种人类癌细胞系的生长,特别是 HCT-116。基于这些令人信服的证据,我们认为该化合物系列可以提供有前途的化学实体,作为具有潜在细胞活性的新型 CDC25B 和 PTP1B 抑制剂。此外,从易于获得和生物相容的氨基酸和糖模板开始的“点击”策略将允许有效地、有成效地构建丰富的新型 PTP 抑制剂文库。